For instance, only 51% carriers of RET p.Val804Met in a German cohort went on to develop MTC, raising the question whether close clinical surveillance was preferrable to risk-reducing thyroidectomy in this circumstance (38). The gene discussed is RET; the disease is medullary thyroid gland carcinoma.